Cleared Special

K142221 - MEMO 3D ReChord

K142221 is the FDA 510(k) clearance for MEMO 3D ReChord by Sorin Group Italia S.R.L.. It is a Class 2 Cardiovascular device (product code KRH) cleared through the Special 510(k) pathway after a 17-day FDA review.

K142221 · Sorin Group Italia S.R.L. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
17d
Days
Class 2
Risk

K142221 is an FDA 510(k) clearance for the MEMO 3D ReChord. Classified as Ring, Annuloplasty (product code KRH), Class II - Special Controls.

Submitted by Sorin Group Italia S.R.L. (Saluggia Vercelli, IT). The FDA issued a Cleared decision on August 29, 2014 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3800 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Sorin Group Italia S.R.L. devices

Submission Details

510(k) Number K142221 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 2014
Decision Date August 29, 2014
Days to Decision 17 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
108d faster than avg
Panel avg: 125d · This submission: 17d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KRH Ring, Annuloplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Sorin Group Canada, Inc.
FABIO DE PASQUALE

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KRH Ring, Annuloplasty

All 35
Devices cleared under the same product code (KRH) and FDA review panel - the closest regulatory comparables to K142221.
NeoForm Annuloplasty Ring
K190506 · Genesee Biomedical, Inc. · Apr 2019
Tri-Ad 2.0 Adams Tricuspid Band
K181132 · Medtronic · May 2018
MEMO 4D
K180411 · Sorin Group Italia S.R.L. · Mar 2018
CARPENTIER-EDWARDS PHYSIO TRICUSPID ANNULOPLASTY RING
K103520 · Edwards Lifesciences, LLC · Jun 2011
MEDTRONIC CONTOUR 3D ANNULOPLASTY RING, MODEL 690R
K101212 · Medtronic, Inc. · Aug 2010
SJM ATTUNE ANNULOPLASTY RING
K092876 · St Jude Medical · Oct 2009